The Patent Finder

Cloudbreak Therapeutics, LLC

7 patents currently held · Updated Nov 21, 2026
9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jun 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

No maintenance fee falls due on this company's record before Nov 21, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,980,901Compositions and Methods for Treating Pterygium
In force
 · Low confidence
In forceLow confidence
US 9,987,223Compositions and Methods for Treating Pterygium
In force
 · Low confidence
In forceLow confidence
US 10,149,819Compositions and Methods for Treating Hyperemia
In force
 · Medium confidence
In forceMedium confidence
US 10,149,820Compositions and Methods for Treating Pterygium
In force
 · Low confidence
In forceLow confidence
US 10,980,741Compositions and Methods for Treating Pterygium Recurrence
In force
 · Low confidence
In forceLow confidence
US 12,186,424Compositions and Methods for Treating Pterygium Recurrence
In force
 · Low confidence
In forceLow confidence
US 11,666,533Emulsion Formulations of Multikinase Inhibitors
In force
 · Low confidence
In forceLow confidence
Also on record, not counted in the 7: 9 patents in force now held by others. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 1 abandoned

Showing 1 to 4 of 4, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page.

ApplicationTitleFiledStatus
18/968,493Compositions and Methods for Treating Pterygium RecurrenceDec 4, 2024Pending
18/307,449Emulsion Formulations of Multikinase InhibitorsApr 26, 2023Pending
17/640,889Methods for Alleviating Pterygium-Associated Worry About Eye AppearanceSep 10, 2020Pending
17/272,105Emulsion Formulations of Multikinase InhibitorsAug 28, 2019Abandoned
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited